U.S.
FDA limits COVID-19 vaccine approval to seniors, high-risk groups
0:48
The FDA will restrict COVID-19 vaccine approval to high-risk groups, requiring new trials for healthy Americans under 65.
Related Stories
My Queue
Latest News
Recently Watched